Coordinated AR and microRNA regulation in prostate cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Androgen receptor (AR) signaling drives prostate cancer (PCa) progression, even in advanced stages.
• MicroRNAs (miRs) are small non-coding RNAs that regulate gene expression and are often dysregulated in cancer.
• The interplay between miRs and AR signaling is critical for understanding PCa development and progression.

Purpose of the Study:

• To review the mechanisms by which miRs are regulated by AR signaling in PCa.
• To summarize how miRs influence AR transcriptional activity, including AR splice variants.
• To assess the clinical implications of this AR-miR cross-talk for PCa biomarkers and therapeutics.

Main Methods:

• Literature review of studies investigating the relationship between miRs and AR signaling in PCa.
• Analysis of mechanisms of miR regulation by AR.
• Examination of the impact of miRs on AR activity and AR splice variants.
• Assessment of clinical applications of miRs in PCa.

Main Results:

• AR signaling modulates miR biogenesis and function.
• miRs, in turn, regulate AR transcriptional activity and expression.
• This bi-directional cross-talk influences PCa progression and castration resistance.
• AR splice variants are also subject to miR regulation.

Conclusions:

• The intricate relationship between AR and miRs presents significant opportunities for PCa treatment.
• miRs hold potential as biomarkers for PCa diagnosis and prognosis.
• Targeting the AR-miR axis could lead to novel therapeutic strategies for advanced PCa.